Last term, in U.S. v. Skrmetti, the Supreme Court upheld a Tennessee statute banning gender-affirming care for minors, ...
A high risk of obstructive sleep apnea (OSA) was associated with higher odds of a composite of depression and mental health ...
After approval in late 2024, Johnson & Johnson's Varipulse PFA system started 2025 on the wrong foot: Its early rollout had ...
Theobromine, a compound found in coffee and dark chocolate, was linked to a reduction in cellular aging, researchers found. ( ...
It's also a relatively recent coverage area for Medicaid. The federal government ordered states to cover autism treatments in ...
In place of our usual "What We Heard This Week" feature, and as part of our year-end wrap-ups, we've selected some of the ...
In August, a CDC employee shared with us their experience of surviving the shooting at the CDC headquarters this summer. As ...
To hear him tell it, Trump is in excellent health. And indeed, none of these examples is unusual for someone who will turn 80 ...
The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...
The woman was admitted to the psychiatric hospital with agitated speech and uncontrolled thoughts. She improved on the ...
As the year comes to a close, the Trump administration seems to be going in two different directions when it comes to the use ...
The FDA granted accelerated approval for the subcutaneous formulation of mosunetuzumab (Lunsumio VELO) for certain patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results